New York, New York (PRWEB) July 01, 2013
Hundreds of Biomet hip lawsuits involving the Biomet M2a Magnum Hip Replacement Program continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, Northern District of Indiana. According to a Memorandum issued by the Court on June 24th, the Biomet hip replacement litigations most recent case management conference was held on June 17, 2013, at which time a quantity of issues had been addressed, including pending motions to strike affirmative defenses, jurisdictional issues connected to the current dismissal of improperly named defendants, and the use of a kind complaint. At the conclusion of the conference, the parties presented a tutorial on the scientific and technical issues involved in the Biomet hip replacement lawsuits. (In re: Biomet M2a Magnum Hip Implant Items Liability Litigation MDL No. 2391)

This most current conference addressed a number of crucial concerns. We are pleased to see the Biomet hip replacement litigation moving ahead, and look forward to extra progress in the future, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and healthcare devices. The Firm is representing customers in Biomet hip lawsuits in the federal multidistrict litigation, and continues to supply free of charge and confidential case evaluations to people who may possibly have been injured by Biomet M2a Magnum implants.

Biomet Hip Replacement Lawsuits
Court documents indicate that far more than 300 Biomet hip lawsuits are now pending in the federal multidistrict litigation. All of the claims allege the Biomet M2a Magnum implants metal-on-metal design can shed dangerous amounts of toxic metal debris as a outcome of wear, top to metallosis and other adverse tissue reactions, as effectively as premature device failure. According to the June 17th Memorandum, the Biomet hip replacement litigations next case management conference has been scheduled for September 23, 2013, whilst a telephonic status conference is set for July 29, 2013.

The U.S. Meals & Drug Administration (FDA) has been reviewing the security of metal-on-metal hip implants like the Biomet M2a Magnum considering that February 2011. In January, the FDA warned that the metal debris shed from these devices can trigger damage to bone and/or tissue surrounding the implant and joint, top to discomfort, implant loosening, device failure, and the want for revision surgery to replace the device. At that time, the agency advised recipients of metal-on-metal hip replacements to undergo metal ion testing if they are experiencing symptoms of hip implant failure. The FDA also stated it had proposed a new rule that would make all-metal hips ineligible for 510(k) approvals, a process which allowed such devices to come to market place with out first undergoing human clinical trials.*

Alleged victims of metal-on-metal hip implant complications associated to the Biomet M2a Magnum hip could be entitled to compensation for their medical expenditures, lost wages and discomfort and suffering. To understand far more about the Biomet hip replacement litigation, please check out Bernstein Liebhard LLPs website. For further data about filing a Biomet hip lawsuit, please contact 1 our attorneys today at 800-511-5092.

*fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About Bernstein Liebhard LLP 
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complicated individual and class action lawsuits nationwide given that 1993, such as these who have been harmed by dangerous drugs, defective health-related devices and customer merchandise. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the leading plaintiffs firms in the nation, for the previous ten consecutive years.

Bernstein Liebhard LLP 
ten East 40th Street 
New York, New York 10016 
800-511-5092

Attorney Advertising.
